Synthetic cathinone-induced anxiety disorder
Synthetic cathinone-induced anxiety disorder is characterized by anxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic arousal, avoidance behavior) that develop during or soon after intoxication with or withdrawal from synthetic cathinones. The intensity or duration of the symptoms is substantially in excess of anxiety symptoms that are characteristic of Synthetic cathinone intoxication or Synthetic cathinone withdrawal. The amount and duration of synthetic cathinone use must be capable of producing anxiety symptoms. The symptoms are not better explained by a primary mental disorder (e.g., an Anxiety and fear-related disorder, a Depressive disorder with prominent anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset of the synthetic cathinone use, if the symptoms persist for a substantial period of time after cessation of the synthetic cathinone use or withdrawal, or if there is other evidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a history of prior episodes not associated with synthetic cathinone use).
Differential diagnosis
When diagnosing Synthetic cathinone-induced anxiety disorder, the following ICD-11 disorders should be considered in the differential diagnosis:
Frequently asked questions
What disorders are in the differential diagnosis of Synthetic cathinone-induced anxiety disorder?
The differential diagnosis of Synthetic cathinone-induced anxiety disorder (6C47.71) includes: Zaburzenie lękowe wywołane środkami pobudzającymi, w tym amfetaminami, metamfetaminą lub metylkatynonem (6C46.71).
WHO ICD-11 source
View this entry in the official WHO ICD-11 browser: 6C47.71 – WHO ICD-11
Notes
Proszę zakodować również jednostkę chorobową (schorzenie) będące przyczyną
Open in interactive browser →